Electronic scaffold and uses thereof

US10987059B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10987059-B2
Application numberUS-201415037129-A
CountryUS
Kind codeB2
Filing dateNov 17, 2014
Priority dateNov 17, 2013
Publication dateApr 27, 2021
Grant dateApr 27, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A device comprising a three-dimensional polymeric element and an electronic element integrated with the polymeric element is disclosed. The electronic element is made up of one or more electrode(s) each individually connectable to a measuring device and/or a controller, and each independently having a thin electrically-isolating layer deposited thereon such that the electrode is exposed to an environment surrounding the electrode at one or more pre-determined locations over the electrode. The device can include cells and/or tissue and/or a therapeutically active agent incorporated within the polymeric material. Processes of fabricating the device, systems for operating the device and methods utilizing same are also disclosed.

First claim

Opening claim text (preview).

What is claimed is: 1. A scaffold device comprising: a three-dimensional polymeric element in a form of a network of microfibers or nanofibers, said polymeric element comprising an electro-responsive polymeric material that undergoes a change in its electronic structure upon application of voltage; an electronic element being integrated with said polymeric element, cells incorporated in and/or on said polymeric element, to form an engineered tissue, and a therapeutically active agent, incorporated in and/or on said polymeric element, and being associated with said electro-responsive polymeric material via electrostatic interactions, to allow release of said agent to said incorporated cells responsively to application of voltage; said electronic element comprising a plurality of electrodes, each electrode being individually connectable to a measuring device and/or a controller, wherein at least one electrode of said plurality of electrodes comprises a conductive core, an electrically-isolating layer, and a nanometric layer of electrically-conductive material sputtered to partially coat the core so as to impart roughness at selected areas of said core, and wherein said electrically-isolating layer is deposited such that a portion of said at least one electrode remains partially uncoated in a plurality of discrete locations over said at least one electrode and is exposed to an environment surrounding said at least one electrode at each location of said plurality of discrete locations. 2. The device of claim 1 , wherein said at least one electrode is exposed to said environment at a tip of said at least one electrode. 3. The device of claim 1 , wherein said thin electrically-isolating layer is an electrically-isolating polymeric layer. 4. The device of claim 1 , wherein said thin electrically-isolating layer has a thickness that ranges from 0.1 micron to 100 microns. 5. The device of claim 1 , wherein at least one dimension of said at least one electrode ranges from 1 micron to 1000 microns. 6. The device of claim 1 , wherein said at least one electrode has a shape of a straight line or of a curved line. 7. The device of claim 6 , wherein said at least one electrode is elastic. 8. The device of claim 1 , wherein each electrode is individually connectable to said controller and wherein said controller is configured for transmitting stimulation signals through said at least one electrode. 9. The device of claim 1 , further comprising a miniature power source mounted in proximity to said electronic element. 10. The device of claim 1 , wherein each electrode is individually connectable to said measuring device, and wherein said measuring device is configured for measuring signals transmitted from the polymeric element through said at least one electrode and/or for measuring signals transmitted from said environment through said at least one electrode. 11. The device of claim 1 , wherein said polymeric element comprises a synthetic polymer. 12. The device of claim 1 , wherein said polymeric element comprises an electrospun fibrous polymeric material. 13. The device of claim 12 , wherein said polymeric material comprises at least one of albumin, a polycaprolactone (PCL), gelatin, a poly(lactic acid) (PLA), a poly(lactic acid-co-glycolic acid) (PLGA), decellularized extracellular matrix and any combination thereof. 14. A system comprising the device of claim 1 and at least one electric device selected from a group consisting of said controller and said measuring device. 15. A method of implantation, comprising: implanting the scaffold device of claim 1 in an organ; and receiving electrical signals from said cells via said electronic element. 16. The method of claim 15 , further comprising transmitting stimulating signals via said electronic element so as to controllably release said therapeutically active agent from said polymeric element. 17. The method of claim 15 , wherein said cells are responsive to electrical stimulation and the method comprising transmitting stimulating signals via said electronic element so as to stimulate said cells. 18. A method of treating disease or disorder caused by dysfunction in, or damage to, an excitable tissue in a subject in need thereof, the method comprising transplanting the scaffold device of claim 1 in the subject. 19. A method of determining a toxicity or an efficacy of a therapeutically active agent, the method comprising: providing the device of claim 1 ; monitoring a function or activity of said cells; and comparing the monitored function or activity of said cells with a function or activity of said cells without the therapeutically active agent, thereby determining the toxicity or the efficacy of said therapeutically active agent to said cells. 20. The scaffold device of claim 1 , wherein each electrode is individually connectable to said controller and wherein said controller is configured for applying said voltage so as to provide spatially and temporally controlled cues to said engineered tissue by said release of said agent.

Assignees

Inventors

Classifications

  • the sensor is mounted in or on a conformable substrate or carrier · CPC title

  • A61B5/686Primary

    Permanently implanted devices, e.g. pacemakers, other stimulators, biochips (A61B5/6861 takes precedence) · CPC title

  • specially adapted for defibrillation or cardioversion · CPC title

  • for reconstruction of the heart, e.g. heart valves · CPC title

  • Heart · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10987059B2 cover?
A device comprising a three-dimensional polymeric element and an electronic element integrated with the polymeric element is disclosed. The electronic element is made up of one or more electrode(s) each individually connectable to a measuring device and/or a controller, and each independently having a thin electrically-isolating layer deposited thereon such that the electrode is exposed to an e…
Who is the assignee on this patent?
Univ Ramot
What technology area does this patent fall under?
Primary CPC classification A61B5/686. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).